ETF MANAGERS GROUP, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$157,448
-89.4%
51,963
-91.9%
0.01%
-92.9%
Q4 2022$1,491,137
+1654.3%
639,973
+1346.3%
0.07%
+2233.3%
Q3 2022$85,000
-33.1%
44,250
-5.8%
0.00%
-25.0%
Q2 2022$127,000
+4.1%
46,988
+14.5%
0.00%
+100.0%
Q1 2022$122,000
-23.3%
41,031
+0.2%
0.00%
-33.3%
Q4 2021$159,000
+2.6%
40,934
+13.1%
0.00%0.0%
Q3 2021$155,000
+72.2%
36,207
+27.3%
0.00%
+200.0%
Q2 2021$90,000
+9.8%
28,451
+9.4%
0.00%0.0%
Q1 2021$82,000
-46.8%
26,009
-37.0%
0.00%
-66.7%
Q4 2020$154,000
+6.9%
41,299
-9.0%
0.00%
-40.0%
Q3 2020$144,000
+269.2%
45,373
+121.1%
0.01%
+400.0%
Q2 2020$39,00020,5200.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2020
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders